Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-07-056916
Filing Date
2007-09-11
Accepted
2007-09-11 16:52:25
Documents
1
Period of Report
2007-09-07

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES rrd172210.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES rrd172210.xml 4 4515
  Complete submission text file 0001181431-07-056916.txt   6362
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Issuer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O IMMUCELL CORP 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 2078782770
ROTHSCHILD JONATHAN E (Reporting) CIK: 0001043218 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12934 | Film No.: 071111436